ENTITY

Royalty Pharma (RPRX US)

9
Analysis
Health CareUnited States
Royalty Pharma plc acquires biopharmaceutical royalties. The Company funds innovation directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators.
more
Company Event14 Feb 2025 22:30 • Upcoming
Add To Calendar
Company Event06 Nov 2024 21:30 • Latest
Company Event08 Aug 2024 20:00
Company Event09 May 2024 20:00
x